CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
1 stories
🇶🇦 Al Jazeera
Life & Tech

The European Union approves a drug that slows the development of type 1 diabetes

The European Commission has approved the marketing of 'Tizeld', the first drug to officially impact the progression of type 1 diabetes in the EU, as announced by the French manufacturer Sanofi.

Jan 13 • 14:25 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.